# Bristol-Myers Squibb Company (BMY) — Q2-2025 Earnings Results

**Report date:** 2025-07-31 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2025

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Misses on EPS — Stock Down 5.81%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.46 | N/A | -12.63% |

### Management Commentary

**Tone:** Defensive

Management expressed concerns about current market conditions impacting performance. They reiterated their commitment to innovation and pipeline development.

**Key quotes:**

> Management acknowledged the challenges faced during the quarter.

> They emphasized a focus on long-term strategies despite short-term setbacks.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report showed a significant miss on EPS, which contributed to a 5.81% decline in stock price. Investors may be concerned about the company's current challenges and lack of guidance. The management's defensive tone suggests that they are aware of the hurdles ahead but remain focused on long-term growth strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2025_